Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma
Clinical trial NCT01943422 · COMPLETED
Trial details
- NCT number
- NCT01943422
- Sponsor
- John Kirkwood
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2016-11-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.